₹1,483.60
₹-32.50 (-2.14%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹17,341 Cr
P/E
-356.66
ROE
-1.10%
ROCE
0.55%
About OneSource Specialty Pharma Ltd
OneSource Specialty Pharma is engaged in the research, development, manufacture and commercialisation of biological drug products in various injectable formats. OneSource also offers end-to-end Contract Development and Manufacturing Operations services across all phases of pre-clinical and clinical development and commercial supply of biologics.
Founded
2007
CEO
Arun Kumar
Employees
1,773
HQ
Bengalooru, India
About OneSource Specialty Pharma Ltd
OneSource Specialty Pharma is engaged in the research, development, manufacture and commercialisation of biological drug products in various injectable formats. OneSource also offers end-to-end Contract Development and Manufacturing Operations services across all phases of pre-clinical and clinical development and commercial supply of biologics.
Founded:2007
CEO:Arun Kumar
Employees:1,773
HQ:Bengalooru, India
Finished Products
1Sale of Services
₹843.77Cr2Sale of goods
₹627.74CrRaw Materials
1Cost of Materials Consumed
₹476.08CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,925
52W Low
₹1,057
Volume130.04K
Avg VolumeN/A
Beta-0.24
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
-356.66x
Valuation
P/B Ratio
2.97x
Valuation
EPS
₹-4.24
Valuation
Dividend Yield
0.00%
Valuation
ROE
-1.10%
Profitability
ROCE
0.55%
Profitability
Revenue by Segment
Contribution & growth by business line
CDMO
+740.4%100.0%
₹1,444.85 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
13.4%
International
86.6%
Rest of the world39.4%
United States of America (USA)35.0%
India13.4%
Ireland12.1%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.26x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
234.2%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.